Karyopharm Therapeutics, Inc. (KPTI)
0.60
-0.04
(-6.98%)
USD |
NASDAQ |
Oct 08, 16:00
0.6056
+0.01
(+0.93%)
After-Hours: 20:00
Karyopharm Therapeutics Total Return Level : 0.60 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.60 |
| October 07, 2026 | 0.645 |
| October 06, 2026 | 0.6499 |
| October 05, 2026 | 0.6705 |
| October 02, 2026 | 0.8022 |
| October 01, 2026 | 0.8668 |
| September 30, 2026 | 1.22 |
| September 29, 2026 | 1.205 |
| September 28, 2026 | 1.62 |
| September 25, 2026 | 1.62 |
| September 24, 2026 | 1.73 |
| September 23, 2026 | 1.75 |
| September 22, 2026 | 1.82 |
| September 21, 2026 | 1.86 |
| September 18, 2026 | 1.88 |
| September 17, 2026 | 1.79 |
| September 16, 2026 | 1.70 |
| September 15, 2026 | 1.54 |
| September 14, 2026 | 1.60 |
| September 11, 2026 | 1.61 |
| September 10, 2026 | 1.62 |
| September 09, 2026 | 1.69 |
| September 08, 2026 | 1.72 |
| September 04, 2026 | 1.79 |
| September 03, 2026 | 1.77 |
| Date | Value |
|---|---|
| September 02, 2026 | 1.79 |
| September 01, 2026 | 1.85 |
| August 31, 2026 | 2.06 |
| August 28, 2026 | 1.87 |
| August 27, 2026 | 1.94 |
| August 26, 2026 | 1.96 |
| August 25, 2026 | 1.92 |
| August 24, 2026 | 1.86 |
| August 21, 2026 | 1.96 |
| August 20, 2026 | 1.82 |
| August 19, 2026 | 2.00 |
| August 18, 2026 | 1.93 |
| August 17, 2026 | 1.81 |
| August 14, 2026 | 2.02 |
| August 13, 2026 | 1.99 |
| August 12, 2026 | 2.03 |
| August 11, 2026 | 2.10 |
| August 10, 2026 | 1.96 |
| August 07, 2026 | 2.12 |
| August 06, 2026 | 1.95 |
| August 05, 2026 | 1.91 |
| August 04, 2026 | 1.96 |
| August 03, 2026 | 1.97 |
| July 31, 2026 | 1.92 |
| July 30, 2026 | 7.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Madrigal Pharmaceuticals, Inc. | 476.91 |
| Relay Therapeutics, Inc. | 17.41 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Savara, Inc. | 4.83 |